Legault Pierre
SEC CIK 1391045 · EDGAR
BoughtSold
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-04 | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | A - Grant | $0.00 | +24.0K | 114.0K | +27% | $0 | |
| 2025-02-07 | 2025-02-05 | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | A - Grant | $0.00 | +25.0K | 90.0K | +38% | $0 | |
| D | 2025-01-06 | 2025-01-02 | BCYC | BICYCLE THERAPEUTICS PLC | Legault Pierre | Dir | A - Grant | $0.00 | +12.5K | 46.0K | +37% | $0 |
| 2024-02-09 | 2024-02-07 | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | A - Grant | $0.00 | +17.0K | 65.0K | +35% | $0 | |
| D | 2024-01-04 | 2024-01-02 | BCYC | BICYCLE THERAPEUTICS PLC | Legault Pierre | Dir | A - Grant | $0.00 | +12.0K | 33.5K | +56% | $0 |
| 2023-02-03 | 2023-02-02 | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | A - Grant | $0.00 | +16.0K | 48.0K | +50% | $0 | |
| DM | 2023-01-13 | 2023-01-12+ | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | S - Sale+OE | $26.84 | -39.0K | 32.0K | -55% | -$1.05M |
| DM | 2023-01-13 | 2023-01-12+ | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | M - OptEx | $11.05 | +39.0K | 37.0K | New | +$431.0K |
| D | 2023-01-05 | 2023-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Legault Pierre | Dir | A - Grant | $0.00 | +11.5K | 21.5K | +115% | $0 |
| DM | 2022-08-09 | 2022-08-05 | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | M - OptEx | $9.22 | +24.0K | 46.0K | +109% | +$221.3K |
| DM | 2022-08-09 | 2022-08-05 | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | S - Sale+OE | $23.02 | -24.0K | 32.0K | -43% | -$552.5K |
| 2022-02-03 | 2022-02-02 | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 | |
| D | 2022-01-05 | 2022-01-03 | BCYC | BICYCLE THERAPEUTICS PLC | Legault Pierre | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
| DM | 2021-12-22 | 2021-12-20+ | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | S - Sale+OE | $21.56 | -44.0K | 16.0K | -73% | -$948.4K |
| DM | 2021-12-22 | 2021-12-20+ | SNDX | Syndax Pharmaceuticals Inc | Legault Pierre | Dir | M - OptEx | $7.52 | +44.0K | 40.0K | New | +$330.7K |
| DM | 2021-12-22 | 2021-12-20+ | BCYC | BICYCLE THERAPEUTICS PLC | Legault Pierre | Dir | M - OptEx | $8.46 | +150.0K | 7,603 | New | +$1.27M |
| DM | 2021-12-22 | 2021-12-20+ | BCYC | BICYCLE THERAPEUTICS PLC | Legault Pierre | Dir | S - Sale+OE | $57.69 | -150.0K | 0 | -100% | -$8.65M |
Purchase Sale Sale after option exercise All abbreviations